The efficacy and safety of spiramycin in the treatment of nongonococcal urethritis in men

S. Segev, Z. Samra, E. Eliav, N. Rosen, E. Rubinstein

Research output: Contribution to journalArticlepeer-review

Abstract

Twenty-five male patients with nongonococcal urethritis including 15 chlamydial infections were treated with spiramycin for ten days. All but four patients had been treated previously, mostly with tetracyclines. Chlamydia trachomatis was cultured in seven patients and was detected in three additional men by immunofluorescent smear. Five other patients had antibodies to chlamydia, and one patient yielded a positive culture for Ureaplasma urealyticum and Mycoplasma hominis. A succussful clinical response was observed in 64% of the patients; C. trachomatis was eradicated from six of seven patients with positive cultures and the three positive direct smears were negative after treatment. It is concluded that spiramycin can be used effectively for the therapy of acute nongonococcal urethritis, as well as in patients who have failed to respond to previous treatment with tetracyclines and erythromycin.

Original languageEnglish
Pages (from-to)183-187
Number of pages5
JournalJournal of Antimicrobial Chemotherapy
Volume22
Issue numberSUPPL. B
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Dive into the research topics of 'The efficacy and safety of spiramycin in the treatment of nongonococcal urethritis in men'. Together they form a unique fingerprint.

Cite this